Rankings
▼
Calendar
REVB Q4 2019 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3,638
Net Income
-$3,638
EPS (Diluted)
$-6.72
← FY 2019
All Quarters
Q1 2020 →
